Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two primary indications
Anti-Heartburn Medicine This medicine will help temporarily decrease the amount of acid secreted in your stomach, allowing you to better tolerate the duration of your illness and decrease your nausea.
Safety evaluation of frequent application of microbubble-enhanced focused ultrasound blood-brain-barrier opening
It can cause vision disturbances, or it could lead to optic nerve damage
[DOI] [PubMed] [Google Scholar] 172.Ganmaa D., Willett W.C., Li T.Y., Feskanich D., van Dam R.M., Lopez-Garcia E., Hunter D.J., Holmes M.D
Trusted by Researchers Worldwide Consistent Results, Reliable Source